NewsRamp Psychedelics Podcast

NewsRamp Psychedelics Podcast

Explore the emerging world of psychedelics with the 'NewsRamp Psychedelics Podcast.' This podcast delivers the latest news and insights from NewsRamp.com, focusing on research developments, therapeutic applications, and regulatory changes in the psychedelics field. Stay informed on the groundbreaking advancements in this evolving industry.

Episodes

November 13, 2025 2 mins
Cybin Inc., a leading neuropsychiatry company, recently announced its successful second-quarter results and highlighted key advancements in its clinical trials and global regulatory approvals. With a focus on revolutionizing mental healthcare, Cybin is actively developing new treatment options for conditions like major depressive disorder and generalized anxiety disorder. George Tziras, the chief business officer, will be presentin...
Mark as Played
Cybin Inc., a leading neuropsychiatry company, will be hosting a conference call to discuss Q2 results and provide updates on their innovative treatment options for mental health disorders. Founded in 2019, Cybin is focused on developing solutions for major depressive disorder and generalized anxiety disorder, operating in multiple countries including Canada, the U.S., the U.K., and Ireland. For more details, visit Cybin's newsroom...
Mark as Played
Cybin Inc., a Phase 3 clinical stage neuropsychiatry company, is set to have their Chief Business Officer speak at the Guggenheim 2nd Annual Healthcare Innovation Conference. The company is dedicated to transforming mental healthcare through the development of novel drugs like CYB003 and CYB004 for major depressive disorder and generalized anxiety disorder, respectively, with the goal of providing effective and lasting treatment op...
Mark as Played
Global Psychedelic Week 2025 is the first-ever distributed psychedelic conference, gathering 5,000 participants from 100 countries through a hybrid online and in-person model. With over 100 speakers like Rick Doblin and Robin Carhart-Harris, the event aims to spark global conversations on psychedelic science, therapy, and culture. By hosting in-person gatherings worldwide, GPW fosters a truly global movement from the ground up, pro...
Mark as Played
Cybin Inc., a Phase 3 clinical-stage neuropsychiatry company, will have its Chief Medical Officer, Amir Inamdar, speak at the upcoming 2025 Milken Institute Future of Health Summit in Washington, D.C. The company is dedicated to transforming mental healthcare through innovative treatment options like CYB003 for major depressive disorder and CYB004 for generalized anxiety disorder. Operating in multiple countries since its founding ...
Mark as Played
Cybin Inc. has revealed a registered direct offering of common shares and warrants, raising over $175 million in gross proceeds. The offering includes renowned investors and aims to support the development of innovative treatment options for mental health conditions like major depressive disorder and generalized anxiety disorder.
Mark as Played
Global Psychedelic Week 2025 offers a diverse program with seven themed days, over 100 events, and 140 speakers from around the world. From scientific discovery to indigenous wisdom, the event explores the evolving landscape of psychedelic research. Visionary voices like Robin Carhart-Harris and Rick Doblin will discuss the fusion of ancient wisdom and modern science. With 5,000 participants from 100 countries, the event aims to un...
Mark as Played
Global Psychedelic Week 2025 will feature 130 global speakers and 100 in-person events worldwide, including discussions on psychedelic therapies in crisis zones, evidence-based approaches in psychedelic enterprises, indigenous perspectives, women in psychedelics, and the role of psychedelics in addressing climate change. The conference aims to decentralize the conversation and prioritize inclusivity and community, with early bird r...
Mark as Played
NRx Pharmaceuticals is making significant progress in developing preservative-free ketamine-based therapies through two different pathways, including KETAFREE and NRX-100. With FDA approval to remove benzethonium chloride for KETAFREE and Fast Track Designation for NRX-100, the company is demonstrating a commitment to innovative treatments for mental health disorders. CEO Dr. Jonathan Javitt recently highlighted these advancements ...
Mark as Played
NRx Pharmaceuticals Inc. has received FDA approval for a Suitability Petition, allowing them to re-file for their preservative-free ketamine product. This aligns with NRx's focus on developing treatments for suicidal depression and PTSD, while tapping into the growing demand for safer pharmaceutical options in the U.S. market.
Mark as Played
Global Psychedelic Week 2025, the first distributed psychedelic conference, will bring together 5,000 people from 100 countries with 100+ speakers like Rick Doblin and Robin Carhart-Harris. With events in nearly 60 cities and partnerships with 70+ organizations, GPW aims to promote global dialogue and action on psychedelics. Early bird registration is now open at www.globalpsychedelicweek.com.
Mark as Played
Cybin Inc. provided updates on its drug discovery platforms, highlighting key milestones such as upcoming Phase 2 and Phase 3 program data releases for anxiety and depression disorders, along with a strategic manufacturing partnership. The Company's intellectual property portfolio is secured until 2041, with promising response rates and FDA Breakthrough Therapy Designation for its CYB003 program.
Mark as Played
Cybin Inc.'s Chief Medical Officer and Chief Business Officer will be participating in a fireside chat at an upcoming summit to discuss the company's focus on developing innovative treatment options for mental health conditions, including their ongoing Phase 3 and Phase 2 studies for major depressive disorder and generalized anxiety disorder, respectively. Established in 2019, Cybin is a clinical-stage neuropsychiatry company with ...
Mark as Played
NRx Pharmaceuticals' subsidiary HOPE Therapeutics Inc. has acquired Dura Medical, a provider of interventional psychiatry services in Florida, expanding its network. Meanwhile, Cybin Inc. has completed enrollment in its Phase 2 study of CYB004 for Generalized Anxiety Disorder, with topline data expected in Q1 2026, aiming to address the needs of millions of Americans living with GAD.
Mark as Played
Cybin Inc., a neuropsychiatry company, will have their Chief Business Officer participating in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference to discuss their focus on developing new treatment options for mental health conditions, including CYB003 in Phase 3 studies for major depressive disorder and CYB004 in a Phase 2 study for generalized anxiety disorder. Established in 2019, Cybin is actively op...
Mark as Played
Cybin Inc.'s Chief Medical Officer, Amir Inamdar, will be participating in a fireside chat at the Cantor Global Healthcare Conference on September 5, 2025, discussing the company's focus on developing new treatment options for mental health conditions such as major depressive disorder and generalized anxiety disorder. The session will be webcast live and available for replay on Cybin's investor relations website. Founded in 2019, C...
Mark as Played
Cybin Inc. appoints Eric So as Interim CEO following Doug Drysdale's resignation, focusing on advancing clinical pipeline for mental health conditions. Meanwhile, NRx Pharmaceuticals Inc. secures FDA Fast Track designation for IV ketamine formulation NRX-100 in treating suicidal depression, expanding its potential patient pool.
Mark as Played
Psylutions, a pioneering cultivator and manufacturer of psilocybin in Colorado, praises the DEA's decision to advance a petition to reschedule psilocybin for scientific review by the U.S. Department of Health and Human Services. This move is seen as a significant stride towards mainstream acceptance of psychedelics in medicine, offering hope for patients in palliative care and Veterans with PTSD. Psylutions is poised to lead the ch...
Mark as Played
Ketamine Lead Gen partners with HealingMaps and Healing Health Alliance to support the growth of Ketamine & TMS clinics by providing patient education, digital marketing, and operational solutions. The collaboration aims to enhance clinic profitability and scalability through high-intent patient discovery, measurable marketing strategies, and exclusive benefits for clinic owners.
Mark as Played
Cybin Inc. has been granted approval to start the EMBRACE Phase 3 study of CYB003 in Australia, marking a significant milestone in their development of new treatment options for mental health conditions. This study is part of Cybin's Phase 3 multinational program, PARADIGM, and focuses on major depressive disorder.
Mark as Played

Popular Podcasts

    If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

    Ruthie's Table 4

    For more than 30 years The River Cafe in London, has been the home-from-home of artists, architects, designers, actors, collectors, writers, activists, and politicians. Michael Caine, Glenn Close, JJ Abrams, Steve McQueen, Victoria and David Beckham, and Lily Allen, are just some of the people who love to call The River Cafe home. On River Cafe Table 4, Rogers sits down with her customers—who have become friends—to talk about food memories. Table 4 explores how food impacts every aspect of our lives. “Foods is politics, food is cultural, food is how you express love, food is about your heritage, it defines who you and who you want to be,” says Rogers. Each week, Rogers invites her guest to reminisce about family suppers and first dates, what they cook, how they eat when performing, the restaurants they choose, and what food they seek when they need comfort. And to punctuate each episode of Table 4, guests such as Ralph Fiennes, Emily Blunt, and Alfonso Cuarón, read their favourite recipe from one of the best-selling River Cafe cookbooks. Table 4 itself, is situated near The River Cafe’s open kitchen, close to the bright pink wood-fired oven and next to the glossy yellow pass, where Ruthie oversees the restaurant. You are invited to take a seat at this intimate table and join the conversation. For more information, recipes, and ingredients, go to https://shoptherivercafe.co.uk/ Web: https://rivercafe.co.uk/ Instagram: www.instagram.com/therivercafelondon/ Facebook: https://en-gb.facebook.com/therivercafelondon/ For more podcasts from iHeartRadio, visit the iheartradio app, apple podcasts, or wherever you listen to your favorite shows. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

    Dateline NBC

    Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

    The Bobby Bones Show

    Listen to 'The Bobby Bones Show' by downloading the daily full replay.

    The Breakfast Club

    The World's Most Dangerous Morning Show, The Breakfast Club, With DJ Envy, Jess Hilarious, And Charlamagne Tha God!

Advertise With Us
Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.